{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T06:00:24Z","timestamp":1669356024262},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bionano Genomics, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To identify candidate disease genes of central nervous system (CNS) phenotypes, we created the Neurogenetic Systematic Correlation of Omics-Related Evidence (NeuroSCORE). We identified five genome-wide metrics highly associated with CNS phenotypes to score 19,601 protein-coding genes. Genes scored one point per metric (range: 0\u20135), identifying 8298 scored genes (scores\u2009\u2265\u20091) and 1601 \u201chigh scoring\u201d genes (scores\u2009\u2265\u20093). Using logistic regression, we determined the odds ratio that genes with a NeuroSCORE from 1 to 5 would be associated with known CNS-related phenotypes compared to genes that scored zero. We tested NeuroSCORE using microarray copy number variants (CNVs) in case\u2013control cohorts and aggregate mouse model data. High scoring genes are associated with CNS phenotypes (OR\u2009=\u20095.5, <jats:italic>p<\/jats:italic>\u2009&lt;\u20092<jats:sc>e<\/jats:sc><jats:sup>-16<\/jats:sup>), enriched in case CNVs, and mouse ortholog genes that cause behavioral and nervous system abnormalities. We identified 1058 high scoring genes with no disease association in OMIM. Transforming the logistic regression results indicates high scoring genes have an 84\u201392% chance of being associated with a CNS phenotype. Top scoring genes include <jats:italic>GRIA1, MAP4K4, SF1, TNPO2,<\/jats:italic> and <jats:italic>ZSWIM8<\/jats:italic>. Finally, we interrogated CNVs in the Clinical Genome Resource, finding the majority of clinically significant CNVs contain high scoring genes. These findings can direct future research and improve molecular diagnostics.<\/jats:p>","DOI":"10.1038\/s41598-022-08938-y","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T10:04:10Z","timestamp":1648721050000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NeuroSCORE is a genome-wide omics-based model that identifies candidate disease genes of the central nervous system"],"prefix":"10.1038","volume":"12","author":[{"given":"Kyle W.","family":"Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen G.","family":"Bilancia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rena","family":"Vanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Rimmasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Hom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moises A.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"8938_CR1","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ije\/dyu099","volume":"43","author":"T Koch","year":"2014","unstructured":"Koch, T. 1831: The map that launched the idea of global health. Int. J. Epidemiol. 43, 1014\u20131020 (2014).","journal-title":"Int. J. Epidemiol."},{"key":"8938_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-804571-8.00017-2","author":"TH Tulchinsky","year":"2018","unstructured":"Tulchinsky, T. H. John Snow, Cholera, the broad street pump; waterborne diseases then and now. Case Stud. Public Heal. https:\/\/doi.org\/10.1016\/B978-0-12-804571-8.00017-2 (2018).","journal-title":"Case Stud. Public Heal."},{"key":"8938_CR3","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/s41436-019-0554-6","volume":"21","author":"S Srivastava","year":"2019","unstructured":"Srivastava, S. et al. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders. Genet. Med. 21, 2413\u20132421 (2019).","journal-title":"Genet. Med."},{"key":"8938_CR4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature14135","volume":"519","author":"T Fitzgerald","year":"2015","unstructured":"Fitzgerald, T. et al. Large-scale discovery of novel genetic causes of developmental disorders. Nature 519, 223\u2013228 (2015).","journal-title":"Nature"},{"key":"8938_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10048-018-0544-x","volume":"19","author":"TM Bardakjian","year":"2018","unstructured":"Bardakjian, T. M. et al. Genetic test utilization and diagnostic yield in adult patients with neurological disorders. Neurogenetics 19, 105\u2013110 (2018).","journal-title":"Neurogenetics"},{"key":"8938_CR6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jama.2015.10078","volume":"314","author":"K Tammimies","year":"2015","unstructured":"Tammimies, K. et al. Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disorder. J. Am. Med. Assoc. 314, 895\u2013903 (2015).","journal-title":"J. Am. Med. Assoc."},{"key":"8938_CR7","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/s41436-020-0872-8","volume":"22","author":"S Heide","year":"2020","unstructured":"Heide, S. et al. Prenatal exome sequencing in 65 fetuses with abnormality of the corpus callosum: contribution to further diagnostic delineation. Genet. Med. 22, 1887\u20131891 (2020).","journal-title":"Genet. Med."},{"key":"8938_CR8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41431-018-0299-8","volume":"27","author":"SM Papuc","year":"2019","unstructured":"Papuc, S. M. et al. The role of recessive inheritance in early-onset epileptic encephalopathies: a combined whole-exome sequencing and copy number study. Eur. J. Hum. Genet. 27, 408\u2013421 (2019).","journal-title":"Eur. J. Hum. Genet."},{"key":"8938_CR9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41586-020-2832-5","volume":"10","author":"J Kaplanis","year":"2020","unstructured":"Kaplanis, J. et al. Evidence for 28 genetic disorders discovered by combining healthcare and research data. Nature 10, 757\u2013762 (2020).","journal-title":"Nature"},{"key":"8938_CR10","first-page":"1","volume":"9","author":"AK Pandey","year":"2014","unstructured":"Pandey, A. K., Lu, L., Wang, X., Homayouni, R. & Williams, R. W. Functionally enigmatic genes: a case study of the brain ignorome. PLoS ONE 9, 1\u201311 (2014).","journal-title":"PLoS ONE"},{"key":"8938_CR11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285\u2013291 (2016).","journal-title":"Nature"},{"key":"8938_CR12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41588-018-0294-6","volume":"51","author":"JM Havrilla","year":"2019","unstructured":"Havrilla, J. M., Pedersen, B. S., Layer, R. M. & Quinlan, A. R. A map of constrained coding regions in the human genome. Nat. Genet. 51, 88\u201395 (2019).","journal-title":"Nat. Genet."},{"key":"8938_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/531210","author":"KJ Karczewski","year":"2019","unstructured":"Karczewski, K. J. et al. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv https:\/\/doi.org\/10.1101\/531210 (2019).","journal-title":"bioRxiv"},{"key":"8938_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"L Brueggeman","year":"2020","unstructured":"Brueggeman, L., Koomar, T. & Michaelson, J. J. Forecasting risk gene discovery in autism with machine learning and genome-scale data. Sci. Rep. 10, 1\u201311 (2020).","journal-title":"Sci. Rep."},{"key":"8938_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-017-0444-y","volume":"9","author":"S Freytag","year":"2017","unstructured":"Freytag, S., Burgess, R., Oliver, K. L. & Bahlo, M. brain-coX: Investigating and visualising gene co-expression in seven human brain transcriptomic datasets. Genome Med. 9, 1\u20139 (2017).","journal-title":"Genome Med."},{"key":"8938_CR16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(13)70011-5","volume":"12","author":"A Moreno-De-Luca","year":"2013","unstructured":"Moreno-De-Luca, A. et al. Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence. Lancet Neurol. 12, 406\u2013414 (2013).","journal-title":"Lancet Neurol."},{"key":"8938_CR17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamapsychiatry.2015.2692","volume":"73","author":"AJ Gonzalez-Mantilla","year":"2016","unstructured":"Gonzalez-Mantilla, A. J., Moreno-De-Luca, A., Ledbetter, D. H. & Martin, C. L. A cross-disorder method to identify novel candidate genes for developmental brain disorders. JAMA Psych. 73, 275\u2013283 (2016).","journal-title":"JAMA Psych."},{"key":"8938_CR18","doi-asserted-by":"crossref","first-page":"D801","DOI":"10.1093\/nar\/gky1056","volume":"47","author":"CJ Bult","year":"2019","unstructured":"Bult, C. J. et al. Mouse genome database (MGD) 2019. Nucl. Acids Res. 47, D801\u2013D806 (2019).","journal-title":"Nucl. Acids Res."},{"key":"8938_CR19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/gim.2014.178","volume":"17","author":"M Uddin","year":"2015","unstructured":"Uddin, M. et al. A high-resolution copy number variation resource for clinical and population genetics. Genet. Med. 17, 747\u2013752 (2015).","journal-title":"Genet. Med."},{"key":"8938_CR20","unstructured":"Zarrei, M. et al. A large data resource of genomic copy number variation across neurodevelopmental disorders. Genomic Med. 4, (2019)."},{"key":"8938_CR21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ajhg.2014.02.001","volume":"94","author":"S Jacquemont","year":"2014","unstructured":"Jacquemont, S. et al. A higher mutational burden in females supports a \u2018female protective model\u2019 in neurodevelopmental disorders. Am. J. Hum. Genet. 94, 415\u2013425 (2014).","journal-title":"Am. J. Hum. Genet."},{"key":"8938_CR22","first-page":"1","volume":"17","author":"KS Ho","year":"2016","unstructured":"Ho, K. S. et al. Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders using an ultra-high resolution chromosomal microarray optimized for neurodevelopmental disorders. Int. J. Mol. Sci. 17, 1\u201314 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"8938_CR23","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1093\/hmg\/ddz176","volume":"28","author":"N Kopp","year":"2019","unstructured":"Kopp, N., McCullough, K., Maloney, S. E. & Dougherty, J. D. Gtf2i and Gtf2ird1 mutation do not account for the full phenotypic effect of the Williams syndrome critical region in mouse models. Hum. Mol. Genet. 28, 3443\u20133465 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"8938_CR24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mcp.2017.12.005","volume":"40","author":"T Chailangkarn","year":"2018","unstructured":"Chailangkarn, T., Noree, C. & Muotri, A. R. The contribution of GTF2I haploinsufficiency to Williams syndrome. Mol. Cell. Probes 40, 45\u201351 (2018).","journal-title":"Mol. Cell. Probes"},{"key":"8938_CR25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2015.01.007","volume":"2","author":"E Cartier","year":"2015","unstructured":"Cartier, E. et al. Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors. EBioMedicine 2, 135\u2013146 (2015).","journal-title":"EBioMedicine"},{"key":"8938_CR26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamapsychiatry.2016.3798","volume":"74","author":"MS Reuter","year":"2017","unstructured":"Reuter, M. S. et al. Diagnostic yield and novel candidate genes by exome sequencing in 152 consanguineous families with neurodevelopmental disorders. JAMA Psych. 74, 293\u2013299 (2017).","journal-title":"JAMA Psych."},{"key":"8938_CR27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ng.3789","volume":"49","author":"JA Kosmicki","year":"2017","unstructured":"Kosmicki, J. A. et al. Refining the role of de novo protein truncating variants in neurodevelopmental disorders using population reference samples. Nat. Genet. 49, 504\u2013510 (2017).","journal-title":"Nat. Genet."},{"key":"8938_CR28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajmg.a.20496","volume":"123A","author":"CA Morris","year":"2003","unstructured":"Morris, C. A. et al. GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region. Am. J. Med. Genet. 123A, 45\u201359 (2003).","journal-title":"Am. J. Med. Genet."},{"key":"8938_CR29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13041-019-0487-7","volume":"12","author":"R Mao","year":"2019","unstructured":"Mao, R. et al. LIMK1 and LIMK2 regulate cortical development through affecting neural progenitor cell proliferation and migration. Mol. Brain 12, 67 (2019).","journal-title":"Mol. Brain"},{"key":"8938_CR30","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/hmg\/ddw010","volume":"25","author":"MA Lalli","year":"2016","unstructured":"Lalli, M. A. et al. Haploinsufficiency of BAZ1B contributes to Williams syndrome through transcriptional dysregulation of neurodevelopmental pathways. Hum. Mol. Genet. 25, 1294\u20131306 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"8938_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12891-019-3017-y","volume":"21","author":"Z Li","year":"2020","unstructured":"Li, Z. et al. The mutational burden and oligogenic inheritance in klippel-feil syndrome. BMC Musculoskelet. Disord. 21, 1\u20139 (2020).","journal-title":"BMC Musculoskelet. Disord."},{"key":"8938_CR32","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ajpath.2011.12.008","volume":"180","author":"S Capossela","year":"2012","unstructured":"Capossela, S. et al. Growth defects and impaired cognitivebehavioral abilities in mice with knockout for Eif4h, a gene located in the mouse homolog of the Williams-beuren syndrome critical region. Am. J. Pathol. 180, 1121\u20131135 (2012).","journal-title":"Am. J. Pathol."},{"key":"8938_CR33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nmat3865","volume":"13","author":"J Willsey","year":"2014","unstructured":"Willsey, J. et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 13, 216\u2013221 (2014).","journal-title":"Nature"},{"key":"8938_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"J Seidlitz","year":"2020","unstructured":"Seidlitz, J. et al. Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders. Nat. Commun. 11, 1\u201314 (2020).","journal-title":"Nat. Commun."},{"key":"8938_CR35","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/ajmg.a.40359","volume":"176","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y. et al. Variance of IQ is partially dependent on deletion type among 1427 22q11.2 deletion syndrome subjects. Am. J. Med. Genet. A 176, 2172\u20132181 (2018).","journal-title":"Am. J. Med. Genet. A"},{"key":"8938_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13039-018-0388-y","volume":"11","author":"L Lovrecic","year":"2018","unstructured":"Lovrecic, L. et al. Microduplication in the 2p16.1p15 chromosomal region linked to developmental delay and intellectual disability. Mol. Cytogenet. 11, 1\u20136 (2018).","journal-title":"Mol. Cytogenet."},{"key":"8938_CR37","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ejpn.2015.07.013","volume":"19","author":"A Mimouni-Bloch","year":"2015","unstructured":"Mimouni-Bloch, A., Yeshaya, J., Kahana, S., Maya, I. & Basel-Vanagaite, L. A de-novo interstitial microduplication involving 2p16.1-p15 and mirroring 2p16.1-p15 microdeletion syndrome: clinical and molecular analysis. Eur. J. Paediatr. Neurol. 19, 711\u2013715 (2015).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"8938_CR38","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tjog.2018.06.018","volume":"57","author":"C-P Chen","year":"2018","unstructured":"Chen, C.-P. et al. Prenatal diagnosis of a 3.2-Mb 2p16.1-p15 duplication associated with familial intellectual disability. Taiwan J. Obstet. Gynecol. 57, 578\u2013582 (2018).","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"8938_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.85461","volume":"1","author":"H Bagheri","year":"2016","unstructured":"Bagheri, H. et al. Identifying candidate genes for 2p15p16.1 microdeletion syndrome using clinical, genomic, and functional analysis. JCI Insight 1, 1\u201320 (2016).","journal-title":"JCI Insight"},{"key":"8938_CR40","first-page":"1","volume":"14","author":"Y-H Wang","year":"2020","unstructured":"Wang, Y.-H., Ding, Z.-Y., Cheng, Y.-J., Chien, C.-T. & Huang, M.-L. An efficient screen for cell-intrinsic factors identifies the chaperonin CCT and multiple conserved mechanisms as mediating dendrite morphogenesis. Front. Cell. Neurosci. 14, 1\u201318 (2020).","journal-title":"Front. Cell. Neurosci."},{"key":"8938_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13072-019-0264-y","volume":"12","author":"A Alfert","year":"2019","unstructured":"Alfert, A., Moreno, N. & Kerl, K. The BAF complex in development and disease. Epigenet. Chromatin 12, 1\u201315 (2019).","journal-title":"Epigenet. Chromatin"},{"key":"8938_CR42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.conb.2019.04.010","volume":"59","author":"JV Goodman","year":"2019","unstructured":"Goodman, J. V. & Bonni, A. Regulation of neuronal connectivity in the mammalian brain by chromatin remodeling. Curr. Opin. Nuerobiol. 59, 59\u201368 (2019).","journal-title":"Curr. Opin. Nuerobiol."},{"key":"8938_CR43","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s00018-016-2168-3","volume":"73","author":"D Van De Willige","year":"2016","unstructured":"Van De Willige, D., Hoogenraad, C. C. & Akhmanova, A. Microtubule plus-end tracking proteins in neuronal development. Cell. Mol. Life Sci. 73, 2053\u20132077 (2016).","journal-title":"Cell. Mol. Life Sci."},{"key":"8938_CR44","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.3390\/ijms15034671","volume":"15","author":"A Mietelska-Porowska","year":"2014","unstructured":"Mietelska-Porowska, A., Wasik, U., Goras, M., Filipek, A. & Niewiadomska, G. Tau protein modifications and interactions: their role in function and dysfunction. Int. J. Mol. Sci. 15, 4671\u20134713 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"8938_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.00001","volume":"11","author":"S Shukla","year":"2020","unstructured":"Shukla, S. & Tekwani, B. L. Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation. Front. Pharmacol. 11, 1\u201320 (2020).","journal-title":"Front. Pharmacol."},{"key":"8938_CR46","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/bies.201600144","volume":"38","author":"IA Sawyer","year":"2016","unstructured":"Sawyer, I. A., Sturgill, D., Sung, M., Hager, G. L. & Dundr, M. Cajal body function in genome organization and transcriptome diversity. BioEssays 38, 1197\u20131208 (2016).","journal-title":"BioEssays"},{"key":"8938_CR47","doi-asserted-by":"crossref","unstructured":"Bergstrand, S. et al. Biallelic mutations in WRAP53 result in dysfunctional telomeres, Cajal bodies and DNA repair, thereby causing Hoyeraal\u2013Hreidarsson syndrome. Cell Death Dis. 11, (2020).","DOI":"10.1038\/s41419-020-2421-4"},{"key":"8938_CR48","first-page":"1","volume":"21","author":"F Limanaqi","year":"2020","unstructured":"Limanaqi, F. et al. Promiscuous roles of autophagy and proteasome in neurodegenerative proteinopathies. Int. J. Mol. Sci. 21, 1\u201331 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"8938_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mgg3.1374","volume":"8","author":"AM Olthof","year":"2020","unstructured":"Olthof, A. M., Rasmussen, J. S., Campeau, P. M. & Kanadia, R. N. Disrupted minor intron splicing is prevalent in Mendelian disorders. Mol. Genet. Genomic Med. 8, 1\u201314 (2020).","journal-title":"Mol. Genet. Genomic Med."},{"key":"8938_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmolb.2019.00161","volume":"6","author":"MP Thelen","year":"2020","unstructured":"Thelen, M. P. & Kye, M. J. The role of RNA binding proteins for local mRNA translation: implications in neurological disorders. Front. Mol. Biosci. 6, 1\u201313 (2020).","journal-title":"Front. Mol. Biosci."},{"key":"8938_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1008287","volume":"16","author":"JM Rodriguez","year":"2020","unstructured":"Rodriguez, J. M., Pozo, F., Di Domenico, T., Vazquez, J. & Tress, M. L. An analysis of tissue-specific alternative splicing at the protein level. PLoS Comput. Biol. 16, 1\u201324 (2020).","journal-title":"PLoS Comput. Biol."},{"key":"8938_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells9112500","volume":"9","author":"M Garcia-Forn","year":"2020","unstructured":"Garcia-Forn, M., Boitnott, A., Akpinar, Z. & De Rubeis, S. Linking autism risk genes to disruption of cortical development. Cells 9, 1\u201324 (2020).","journal-title":"Cells"},{"key":"8938_CR53","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ajhg.2020.06.013","volume":"107","author":"MJ Guillen Sacoto","year":"2020","unstructured":"Guillen Sacoto, M. J. et al. De Novo variants in the ATPase module of MORC2 cause a neurodevelopmental disorder with growth retardation and variable craniofacial dysmorphism. Am. J. Hum. Genet. 107, 352\u2013363 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"8938_CR54","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/s41380-018-0049-x","volume":"24","author":"SM Williams","year":"2019","unstructured":"Williams, S. M. et al. An integrative analysis of non-coding regulatory DNA variations associated with autism spectrum disorder. Mol. Psych. 24, 1707\u20131719 (2019).","journal-title":"Mol. Psych."},{"key":"8938_CR55","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1126\/science.aar6731","volume":"362","author":"HC Martin","year":"2018","unstructured":"Martin, H. C. et al. Quantifying the contribution of recessive coding variation to developmental disorders. Science 362, 1161\u20131164 (2018).","journal-title":"Science"},{"key":"8938_CR56","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41588-018-0288-4","volume":"51","author":"BP Coe","year":"2019","unstructured":"Coe, B. P. et al. Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity. Nat. Genet. 51, 106\u2013116 (2019).","journal-title":"Nat. Genet."},{"key":"8938_CR57","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.neuron.2016.02.024","volume":"89","author":"A Takata","year":"2016","unstructured":"Takata, A., Ionita-laza, I., Gogos, J. A., Xu, B. & Karayiorgou, M. D. Novo synonymous mutations in regulatory elements contribute to the genetic etiology of autism and schizophrenia. Neuron 89, 940\u2013947 (2016).","journal-title":"Neuron"},{"key":"8938_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-019-0665-5","volume":"10","author":"J Martin","year":"2020","unstructured":"Martin, J. et al. A brief report: de novo copy number variants in children with attention deficit hyperactivity disorder. Transl. Psych. 10, 1\u20136 (2020).","journal-title":"Transl. Psych."},{"key":"8938_CR59","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41588-020-0695-1","volume":"52","author":"SC Jin","year":"2020","unstructured":"Jin, S. C. et al. Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nat. Genet. 52, 1046\u20131056 (2020).","journal-title":"Nat. Genet."},{"key":"8938_CR60","first-page":"1067","volume":"18","author":"AS Allen","year":"2013","unstructured":"Allen, A. S. et al. De novo mutations in the classic epileptic encephalopathies. Nature 18, 1067\u20131073 (2013).","journal-title":"Nature"},{"key":"8938_CR61","first-page":"1","volume":"8","author":"F Zou","year":"2012","unstructured":"Zou, F. et al. Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet. 8, 1\u201316 (2012).","journal-title":"PLoS Genet."},{"key":"8938_CR62","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ng.3092","volume":"46","author":"BP Coe","year":"2014","unstructured":"Coe, B. P. et al. Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nat. Genet. 46, 1063\u20131071 (2014).","journal-title":"Nat. Genet."},{"key":"8938_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"M Uddin","year":"2016","unstructured":"Uddin, M. et al. Indexing effects of copy number variation on genes involved in developmental delay. Sci. Rep. 6, 1\u201312 (2016).","journal-title":"Sci. Rep."},{"key":"8938_CR64","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.1262110","volume":"348","author":"Gte","year":"2015","unstructured":"Consortium & Gte,. The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648\u2013660 (2015).","journal-title":"Science"},{"key":"8938_CR65","doi-asserted-by":"crossref","first-page":"D804","DOI":"10.1093\/nar\/gkw865","volume":"45","author":"TN Turner","year":"2017","unstructured":"Turner, T. N. et al. denovo-db: a compendium of human de novo variants. Nucl. Acids Res. 45, D804\u2013D811 (2017).","journal-title":"Nucl. Acids Res."},{"key":"8938_CR66","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ng.2980","volume":"46","author":"M Uddin","year":"2014","unstructured":"Uddin, M. et al. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nat. Genet. 46, 742\u2013747 (2014).","journal-title":"Nat. Genet."},{"key":"8938_CR67","doi-asserted-by":"publisher","unstructured":"Ashwell, K. W. S. & Mai, J. K. Chapter 3-fetal development of the central nervous system. in The Human Nervous System (Third Edition) (eds. Mai, J. K. & Paxinos, G.) 31\u201379 (Academic Press, 2012). doi:https:\/\/doi.org\/10.1016\/B978-0-12-374236-0.10003-3","DOI":"10.1016\/B978-0-12-374236-0.10003-3"},{"key":"8938_CR68","doi-asserted-by":"crossref","unstructured":"Sj\u00f6stedt, E., et al. An atlas of the protein-coding genes in the human, pig, and mouse brain. Science 367, (2020).","DOI":"10.1126\/science.aay5947"},{"key":"8938_CR69","doi-asserted-by":"crossref","first-page":"D419","DOI":"10.1093\/nar\/gky1038","volume":"47","author":"H Mi","year":"2019","unstructured":"Mi, H., Muruganujan, A., Ebert, D., Huang, X. & Thomas, P. D. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucl. Acids Res. 47, D419\u2013D426 (2019).","journal-title":"Nucl. Acids Res."},{"key":"8938_CR70","doi-asserted-by":"crossref","unstructured":"Consortium, T. G. O., et al. Gene ontology\u202f: tool for the unification of biology. Nat. Genet. 25, 25\u201329 (2000).","DOI":"10.1038\/75556"},{"key":"8938_CR71","doi-asserted-by":"crossref","unstructured":"Consortium, T. G. O. The gene ontology resource: 20 years and still GOing strong. Nucl. Acids Res. 47, 330\u2013338 (2019).","DOI":"10.1093\/nar\/gky1055"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08938-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08938-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08938-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:20:30Z","timestamp":1669339230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08938-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8938"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-08938-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"assertion":[{"value":"6 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Megan Martin, Rena Vanzo, Dr. Colleen G. Bilancia, and Dr. Moises Serrano all are employees of and hold stock options in Bionano Genomics, Inc. Kyle W. Davis and Megan Rimmasch were previously employed by Bionano Genomics, Inc. and Kyle W. Davis own stock options in Bionano Genomics, Inc. Dr. Mohammed Uddin is listed as an inventor on a patent application for his work on critical exon indexing (upon which the Index gene metric is based); the patent is held by Toronto Hospital for Sick Children and licensed by Lineagen Inc, a Bionano Genomics Company. Yolanda Hom has declared no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5427"}}